ID

29055

Descripción

Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Palabras clave

  1. 5/10/17 5/10/17 -
  2. 22/2/18 22/2/18 -
  3. 22/2/18 22/2/18 -
  4. 22/2/18 22/2/18 -
  5. 17/9/21 17/9/21 -
Titular de derechos de autor

gsk

Subido en

22 de febrero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Ropinirole Case Report Form GSK RRL100013

INVESTIGATIONAL PRODUCT

Investigational Product
Descripción

Investigational Product

Alias
UMLS CUI-1
C0304229
Planned timepoint
Descripción

Planned timepoint

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348792
Blinded dose level
Descripción

Blinded dose level

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0304229
Start Date
Descripción

Start Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
Stop Date
Descripción

Stop Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0304229
IP Container No. 1
Descripción

IP Container No 1

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
IP Container No. 2
Descripción

IP Container No 2

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
Has the subject missed investigational product for >2 consecutive days
Descripción

Has the subject missed investigational product for >2 consecutive days

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0457454
Average number of hours between early and late dose
Descripción

Average number of hours between early and late dose

Tipo de datos

text

Similar models

INVESTIGATIONAL PRODUCT

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Item
Planned timepoint
integer
C2348792 (UMLS CUI [1])
Code List
Planned timepoint
CL Item
Baseline (1)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
Day 3 (2)
(Comment:en)
CL Item
Vital signs (3)
C0518766 (UMLS CUI-1)
(Comment:en)
Blinded dose level
Item
Blinded dose level
integer
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 1
Item
IP Container No. 1
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 2
Item
IP Container No. 2
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Has the subject missed investigational product for >2 consecutive days
Item
Has the subject missed investigational product for >2 consecutive days
boolean
C0457454 (UMLS CUI [1])
Average number of hours between early and late dose
Item
Average number of hours between early and late dose
text

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial